PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients
作者： F. Perrone , A. Lampis , M. Orsenigo , M. Di Bartolomeo , A. Gevorgyan
关键词:
摘要: Background: It has been reported that KRAS mutations (and to a lesser extent KRAS mutations with the BRAF V600E mutation) negatively affect response to anti-epidermal growth …
annalsofoncology.org
oup.com
oxfordjournals.org
elsevier.com
paperity.org参考文章(27)
Shuang-Yin Han, Hideaki Kato, Shunsuke Kato, Takao Suzuki, Hiroyuki Shibata, Seiichi Ishii, Ken-ichi Shiiba, Seiki Matsuno, Ryunosuke Kanamaru, Chikashi Ishioka, None, Functional Evaluation of PTEN Missense Mutations Using in Vitro Phosphoinositide Phosphatase Assay Cancer Research. ,vol. 60, pp. 3147- 3151 ,(2000)
Mohamed Hebbar, Agne`s Wacrenier, Christophe Desauw, Olivier Romano, Ste??phane Cattan, Jean-Pierre Triboulet, Francois-Rene?? Pruvot, Lack of usefulness of epidermal growth factor receptor expression determination for cetuximab therapy in patients with colorectal cancer. Anti-Cancer Drugs. ,vol. 17, pp. 855- 857 ,(2006) , 10.1097/01.CAD.0000217425.44584.9F
Vítor Trovisco, Paula Soares, Ricardo Soares, João Magalhães, Pedro Sá-Couto, Manuel Sobrinho-Simões, None, A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma. Human Pathology. ,vol. 36, pp. 694- 697 ,(2005) , 10.1016/J.HUMPATH.2005.04.011
F Di Fiore, F Blanchard, F Charbonnier, F Le Pessot, A Lamy, M P Galais, L Bastit, A Killian, R Sesboüé, J J Tuech, A M Queuniet, B Paillot, J C Sabourin, F Michot, P Michel, T Frebourg, Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy. British Journal of Cancer. ,vol. 96, pp. 1166- 1169 ,(2007) , 10.1038/SJ.BJC.6603685
M Ponz-Sarvise, J Rodriguez, A Viudez, A Chopitea, A Calvo, J García-Foncillas, I Gil-Bazo, Epidermal growth factor receptor inhibitors in colorectal cancer treatment: What’s new? World Journal of Gastroenterology. ,vol. 13, pp. 5877- 5887 ,(2007) , 10.3748/WJG.V13.I44.5877
Maria Daniotti, Maria Oggionni, Tiziana Ranzani, Viviana Vallacchi, Valentina Campi, Delia Di Stasi, Gabriella Della Torre, Federica Perrone, Chiara Luoni, Simona Suardi, Milo Frattini, Silvana Pilotti, Andrea Anichini, Gabrina Tragni, Giorgio Parmiani, Marco A Pierotti, Monica Rodolfo, BRAF alterations are associated with complex mutational profiles in malignant melanoma Oncogene. ,vol. 23, pp. 5968- 5977 ,(2004) , 10.1038/SJ.ONC.1207780
Antoine Italiano, Philippe Follana, François-Xavier Caroli, Jean-Luc Badetti, Daniel Benchimol, Georges Garnier, Jean Gugenheim, Juliette Haudebourg, Frédérique Keslair, Gérard Lesbats, Gérard Lledo, Jean-Francois Roussel, Florence Pedeutour, Eric François, Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors for Which FISH Analysis Does Not Detect an Increase in EGFR Gene Copy Number Annals of Surgical Oncology. ,vol. 15, pp. 649- 654 ,(2008) , 10.1245/S10434-007-9667-2
Michael J. O??Brien, Shi Yang, Charline Mack, Huihong Xu, Christopher S. Huang, Elizabeth Mulcahy, Mark Amorosino, Francis A. Farraye, Comparison of Microsatellite Instability, CpG Island Methylation Phenotype, BRAF and KRAS Status in Serrated Polyps and Traditional Adenomas Indicates Separate Pathways to Distinct Colorectal Carcinoma End Points The American Journal of Surgical Pathology. ,vol. 30, pp. 1491- 1501 ,(2006) , 10.1097/01.PAS.0000213313.36306.85
Minaxi Jhawer, Sanjay Goel, Andrew J. Wilson, Cristina Montagna, Yi-He Ling, Do-Sun Byun, Shannon Nasser, Diego Arango, Joongho Shin, Lidija Klampfer, Leonard H. Augenlicht, Roman Perez Soler, John M. Mariadason, PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab Cancer Research. ,vol. 68, pp. 1953- 1961 ,(2008) , 10.1158/0008-5472.CAN-07-5659
Leonardo Salmena, Arkaitz Carracedo, Pier Paolo Pandolfi, Tenets of PTEN tumor suppression. Cell. ,vol. 133, pp. 403- 414 ,(2008) , 10.1016/J.CELL.2008.04.013